Eudendron Srl

29/11/2016

29/11/2016

Eudendron is attending EORTC-NCI-AACR-2016

25/04/2016

25/04/2016

London calling

25/04/2016

Eudendron is at the BioTrinity 2016 London

07/03/2016

Eudendron will be presenting a showcase at BioTrinity 2016 in London on 26th of April

http://www.biotrinity.com/company-showcase-participants

The listing below shows the participants in the BioTrinity and MediTrinity showcases, either early or later stage, in date/time order.

01/04/2015

Eudendron is in the BioInItaly 2015 Final

14/03/2015

Eudendron is one of the 20 companies admitted to the Boot Camp (Phase 2) of BioInItaly Investment Forum & Intesa Start-up Initiative 2015

http://assobiotec.federchimica.it/eventi/eventi-associativi/2015/04/21/default-calendar/bioinitaly-investment-forum-intesa-sanpaolo-start-up-initiative-2015

21/01/2015

Eudendron is pleased to announce that on the 5th of February will attend the 9th Swiss-Scandinavian Bio-Business Seminar in Zurich (Switzerland)

http://www.eudendron.com/ #!news/c3q5

Eudendron is an Oncology Drug Discovery company focused on the development of a new generation of Kinase inhibitors for Targeted Therapy in Oncology

21/08/2014

Eudendron is pleased to announced that its lead compound EUD-GK-91 has succesfully completed PoC in cell showing a preferential and significant inhibition of the drug resistant gatekeeper mutation in several NSCLC kinase targets

www.eudendron.com

28/09/2012

13th September 2012

Eudendron is glad to announce that a collaboration agreement has been signed with Zebra Ventures
http://www.twozebras.com/

28/09/2012

29th September 2012

Eudendron has established its office at the BioIndustryPark Silvano Fumero - Colleretto Giacosa (TO) - ITALY
http://www.bioindustrypark.eu/

Joomla - the dynamic portal engine and content management system